$CPRX·4

CATALYST PHARMACEUTICAL PARTNERS, INC. · Oct 20, 4:34 PM ET

CATALYST PHARMACEUTICAL PARTNERS, INC. 4

4 · CATALYST PHARMACEUTICAL PARTNERS, INC. · Filed Oct 20, 2014

Insider Transaction Report

Form 4
Period: 2014-10-17
Winship M Douglas
V.P. of Regulatory Operations
Transactions
  • Exercise/Conversion

    Common stock, par value $0.001 per share

    2014-10-17$0.90/sh+125,000$112,500142,294 total
  • Tax Payment

    Common stock, par value $0.001 per share

    2014-10-1745,36396,931 total
  • Exercise/Conversion

    Options to purchase common stock

    2014-10-17125,000297,500 total
    Exercise: $0.90Exp: 2014-10-20Common Stock (125,000 underlying)
Footnotes (2)
  • [F1]Holder exercised 125,000 options at $0.90 per share on a cashless basis and was issued 79,637 shares based on the October 17, 2014 closing price of $2.48 per share.
  • [F2]The option was granted on October 20, 2009 and vested in three equal annual installments.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4 FOR 10-17-2014